ANTIVIRAL THERAPY FOR HEPATITIS IN DIALYSIS PATIENTS: ALMATY CASE SERIES
2 2025
Изменен: 30.04.2025Путь: Главная / Публикации
ANTIVIRAL THERAPY FOR HEPATITIS IN DIALYSIS PATIENTS: ALMATY CASE SERIES
11401 11402 11403 11404 11405 11406 9644 11291 11407 11408 7666 11409 11410 11411 11412 2 2025
Изменен: 30.04.2025Путь: Главная / Басты бет / Жарияланымдар
ANTIVIRAL THERAPY FOR HEPATITIS IN DIALYSIS PATIENTS: ALMATY CASE SERIES
... HBV+HCV infection. All HCV patients were treated with SOF/VEL for 8–12 weeks. SVR12 and SVR24 were achieved in 100% of HCV-treated patients. The two HBV patients showed complete... ... pangenotypic DAAs and nucleos(t)ide analogs was highly effective and well tolerated in hemodialysis patients with chronic hepatitis B and C. These findings demonstrate the... ... antiviral treatment into routine nephrology care for dialysis-dependent patients in Kazakhstan. Arina Yespotayeva – MD, assistant professor, Kazakh National Medical...
Изменен: 30.04.2025Путь: Главная / Home / Publications
Результаты поиска 1 - 3 из 3
Начало | Пред. | 1 | След. | Конец
Отсортировано по релевантности | Сортировать по дате